Who are Humacyte, Inc.'s main suppliers?

Humacyte, Inc. (HUMAW) key suppliers include: Fresenius Medical Care AG, Fresenius Medical Care AG. View the full supplier network at chainsifter.com/chain/HUMAW.

Who are Humacyte, Inc.'s major customers?

Humacyte, Inc. (HUMAW) key customers include: Fresenius Medical Care AG, Fresenius Medical Care AG. View the full customer network at chainsifter.com/chain/HUMAW.

What sector is Humacyte, Inc. in?

Humacyte, Inc. (HUMAW) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Humacyte, Inc. (HUMAW): 5 Verified Supply Chain Relationships

2Suppliers

2Customers

1Debt Items

18Related Chains

Source-Backed Evidence Depth

Humacyte, Inc. (HUMAW) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

5Total relationships

2Distinct source URLs

1High confidence

0.756Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Humacyte, Inc. Suppliers

Ticker	Name	Confidence	Evidence
FMS	Fresenius Medical Care AG	72%	Reciprocal relationship from FMS graph: Reciprocal relationship from HUMAW graph: Reciprocal relationship from FMS graph: Reciprocal relationship from HUMAW graph: Reciprocal relationship from FMS gr…
FMS	Fresenius Medical Care AG	72%	ither party may terminate the SeraCare Agreement for uncured material breach or for the insolvency of the other party at any time. In addition, either party may terminate the SeraCare Agreement witho…

Humacyte, Inc. Customers

Ticker	Name	Confidence	Evidence
FMS	Fresenius Medical Care AG	72%	least 365 days written notice and we are obligated to provide 180 days’ notice, prior to such a termination. In addition, each party is permitted to terminate the mesh supply agreement for an uncured…
FMS	Fresenius Medical Care AG	72%	Reciprocal relationship from FMS graph: Reciprocal relationship from HUMAW graph: least 365 days written notice and we are obligated to provide 180 days’ notice, prior to such a termination. In addit…

Humacyte, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
HUMAW-DEBT-10116	Warrants outstanding: 32961	90%	xbrl warrant detail from xbrl 2023-12-31.

Humacyte, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Humacyte, Inc..

Humacyte, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Humacyte, Inc..

Humacyte, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
FMS	Fresenius Medical Care AG	100.00	1	['customer', 'supplier']
CTSO	Cytosorbents Corporation	50.00	2
BAX	Baxter International Inc.	50.00	2
BDX	Becton, Dickinson and Company	50.00	2
CHRS	Coherus Oncology, Inc.	50.00	2
EHC	Encompass Health Corporation	50.00	2
FSNUY	Fresenius SE & Co. KGaA	50.00	2
FMCQF	Fresenius Medical Care AG	50.00	2
TKPHF	Takeda Pharmaceutical Company Limited	50.00	2
HUMA	Humacyte, Inc.	50.00	2
THC	Tenet Healthcare Corporation	50.00	2
STMEF	STMicroelectronics N.V.	50.00	2
RYLPF	Koninklijke Philips N.V.	50.00	2
APAM	Artisan Partners Asset Management Inc.	50.00	2
SNYNF	Sanofi	50.00	2
MT	ArcelorMittal S.A.	50.00	2
BSX	Boston Scientific Corporation	50.00	2
OM	Outset Medical, Inc.	50.00	2

Humacyte, Inc. Supply Chain